ilmscore | Glenmark Pharma EBITDA Margin Predictions
N/A
Accuracy

Recent Predictions

Total: 1
Correct: 0
Incorrect: 0
Pending: 1
Prediction
Author
Predicted at
Status
Video
Glenmark Pharma's management targets an EBITDA margin of 19% (likely for FY25 or beyond).
"the real deal is the EBITDA margin target at 19"
May 27, 2024
Pending